Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Bayer lymphoma treatment speeds to FDA approval

September 18, 2017 Sales and Marketing Aliqopa, Bayer, biotech, drugs, pharma, pharmaceutical

The FDA gave Bayer priority review for its treatment Aliqopa (copanlisib) in May of this year, and it quickly came …
News

Santhera ‘surprised’ by European rejection of DMD drug

September 18, 2017 Sales and Marketing Duchenne Muscular Dystrophy, biotech, drugs, pharma, pharmaceutical, santhera

Santhera Pharmaceutical has announced the EMA’s CHMP rejected its treatment for Duchenne muscular dystrophy (DMD) but revealed that it planned …
News

Top Ten most popular articles on Pharmafile.com this week

September 15, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cosentyx, Eli Lilly, Martin Skreli, Teva, pharma, top ten

This week has been a particularly eventful one for the industry: among our top stories, Martin Shkreli finally heads to …
News

FDA approves first-ever biosimilar for cancer treatment

September 15, 2017 Medical Communications, Sales and Marketing Amgen, Cancer, FDA, Mvasi, avastin, biosimilar

The FDA has announced the news that it has awarded approval to the first-ever biosimilar for the treatment of cancer …
News

GSK receives positive opinion for triple-therapy inhaler

September 15, 2017 Medical Communications, Sales and Marketing GSK, biotech, drugs, pharma, pharmaceutical

GSK, alongside its partner Innoviva, has announced that it has received a positive opinion from the EMA’s CHMP for its …
News

Recipharm and Kancera collaborate to manufacture clinical trial supply

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed …
News
Press release

GDPR and Human Data Samples: Being ‘somewhat prepared’ is not enough

September 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, biotech, data, drugs, pharma, pharmaceutical

Thomas Hirse, Partner, and Paetrick Sakowski, Associate, CMS, discuss what pharmaceutical companies need to be aware of ahead of the …
Feature

FDA panel gives GSK’s Shingrix unanimous approval

September 14, 2017 Sales and Marketing GSK, Shingrix, biotech, drugs, pharma, pharmaceutical, shingles

The FDA’s advisory panel has given a strong signal that GSK’s Shingrix should not have too much difficulty getting full …
News

23andMe raises $250m in financing, research points towards its future

September 13, 2017 Research and Development, Sales and Marketing 23andME, biotech, drugs, pharma, pharmaceutical

23andMe made two announcements on the same day that point towards the future of its business: it revealed it had …
News

Recipharm and CTC launch integrated first in human service

September 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, biotech, drugs, pharma, pharmaceutical

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch …
News
Press release

Newly adopted flu vaccine could save 1,700 lives

September 12, 2017 Research and Development, Sales and Marketing biotech, drugs, flu, fluad, pharma, pharmaceutical, seqirus

The Fluad flu vaccine, produced by Seqirus, was approved by the MHRA for use beginning in 2018 and further data …
News

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock

September 12, 2017 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …
News

Teva announces sale of Paragard for $1.1 billion

September 12, 2017 Manufacturing and Production, Sales and Marketing Paragard, Teva, biotech, drugs, pharma, pharmaceutical

Shortly after the news that Teva had finally sealed the deal on a new CEO, it also announced that it …
News

FDA accepts license application for Novartis’ rituximab biosimilar

September 12, 2017 Manufacturing and Production, Sales and Marketing Novartis, Rituxan, Sandoz, biosimilar, rituximab

Sandoz, Novartis’ generics and biosimilars division, has revealed that the FDA has accepted its Biologics License Application (BLA) for a …
News

PrimeVigilance launches new brand and logo

September 12, 2017 Manufacturing and Production, Sales and Marketing pharmacovigilance, primevigilance

PrimeVigilance has launched its new visual identity together with a new website. Additionally, it has begun harmonising its appearance within …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026